Skip to main content
Knight Therapeutics Inc. (TSX:GUD)
Canada flag Canada · Delayed Price · Currency is CAD
5.78
+0.02 (0.35%)
Jun 2, 2025, 12:52 PM EDT

Knight Therapeutics Revenue

Knight Therapeutics had revenue of 88.08M CAD in the quarter ending March 31, 2025, with 1.70% growth. This brings the company's revenue in the last twelve months to 372.78M, up 12.21% year-over-year. In the year 2024, Knight Therapeutics had annual revenue of 371.30M with 13.13% growth.

Revenue (ttm)
372.78M
Revenue Growth
+12.21%
P/S Ratio
1.54
Revenue / Employee
500.37K
Employees
745
Market Cap
573.85M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024371.30M43.11M13.13%
Dec 31, 2023328.20M34.64M11.80%
Dec 31, 2022293.56M50.09M20.57%
Dec 31, 2021243.48M43.96M22.03%
Dec 31, 2020199.52M152.06M320.39%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
dentalcorp Holdings 1.58B
Sienna Senior Living 896.45M
Green Thumb Industries 1.64B
Extendicare 1.47B
Cronos Group 179.08M
Trulieve Cannabis 1.71B
WELL Health Technologies 990.34M
Curaleaf Holdings 1.89B
Revenue Rankings

Knight Therapeutics News

More News